Seniedo, Briah Amari V.

HRN: 21-35-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2022
AMPICILLIN 250MG (VIAL)
08/30/2022
09/27/2022
IV
250mg
Q12
Uti
Waiting Final Action 
08/30/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/30/2022
09/06/2022
IV
75mg
Q24h
Uti
Waiting Final Action 
09/04/2022
CEFUROXIME 750MG (VIAL)
09/04/2022
09/10/2022
IVTT
160 Mg
Q8
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: